I am an 85-year-old woman in relatively good health. I had been taking raloxifene for approximately 45 years. My doctor at the time said that since I had ...

Raloxifene is a selective estrogen receptor modulator used for prevention and treatment of postmenopausal osteoporosis. It acts as an agonist of estrogen in bone but an antagonist in other tissues ...

Patients with osteoporosis who took bisphosphonates, especially risedronate, were at a higher risk of developing acute angle ...

By contrast, no increased stroke risk was associated with raloxifene use in patients with osteoporosis. Previous studies have hinted at a relationship between the use of raloxifene (a selective ...

The pharmacokinetics of raloxifene were investigated in over 1500 women in clinical trials (Table 1). [16] Although most of the women were white and postmenopausal, interpatient variability of ...

Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone. Access nashuatelegraph.com, view our digital edition or use our Full ...